MEN1 family with a novel frameshift mutation

V. Nuzzo, L. Tauchmanové, A. Falchetti, A. Faggiano, F. Marini, S. Piantadosi, M. L. Brandi, L. Leopaldi, A. Colao

Research output: Contribution to journalArticle

Abstract

Multiple endocrine neoplasm type 1 (MEN1) syndrome predisposes to the development of endocrine and non-endocrine tumors with an autosomal dominant pattern of inheritance. Different mutations have been found throughout the gene with a variable phenotype expression. The proband, a Caucasian man, was admitted to our department in 2001, at the age of 51 because of a 1-yr history of diarrhoea and hypertension. He reported a previous intestinal resection for bowel occlusion with a histological diagnosis of unspecified mesenchymal neoplasia. He had also undergone a left adrenalectomy for a large non-functioning adrenal adenoma. Subsequently, he had suffered from gastralgia and melena; a gastroduodenoscopy showed an erosive gastritis. His family history was negative for endocrine disorders. On physical examination, multiple abdominal cutaneous lipomas and facial angiofibromas were observed. Biochemical screening revealed a primary hyperparathyroidism and an increase in circulating levels of PRL, chromogranin-A, gastrin and glucagon. The whole body computed tomography (CT) scan, the 111In-octreotide scan and the pituitary magnetic resonance imaging (MRI) did not reveal any abnormality. The presence of small neuroendocrine tumors was suspected by a positron emission tomography uptake in the epigastric region. The endoscopic ultrasound revealed a pancreatic lesion sized 1.1 cm that is under evaluation. Direct DNA sequencing analysis of the proband MEN1 gene revealed the 579delG frameshift mutation in the exon 3. The genetic screening of the family revealed the same mutation in 3 out of 5 offspring. The biochemical screening revealed some features of the MEN1 syndrome in all three of them. In conclusion, a novel frameshift MEN1 mutation was found in kindred with an apparently negative family history. Our experience confirms that MEN1 syndrome is a complex and underestimated condition, unless specifically investigated by trained specialists.

Original languageEnglish
Pages (from-to)450-456
Number of pages7
JournalJournal of Endocrinological Investigation
Volume29
Issue number5
Publication statusPublished - May 2006

Fingerprint

Multiple Endocrine Neoplasia Type 1
Frameshift Mutation
Mutation
Angiofibroma
Melena
Chromogranin A
Inheritance Patterns
Neuroendocrine Tumors
Primary Hyperparathyroidism
Lipoma
Neoplasm Genes
Adrenalectomy
Gastrins
Genetic Testing
Gastritis
Glucagon
DNA Sequence Analysis
Adenoma
Positron-Emission Tomography
Physical Examination

Keywords

  • Cutaneous angiofibromas
  • Frame-shift mutation
  • MEN1 syndrome
  • Menin
  • Octreoscan octreotide LAR
  • Primary hyperparathyroidism
  • Prolactinoma

ASJC Scopus subject areas

  • Endocrinology

Cite this

Nuzzo, V., Tauchmanové, L., Falchetti, A., Faggiano, A., Marini, F., Piantadosi, S., ... Colao, A. (2006). MEN1 family with a novel frameshift mutation. Journal of Endocrinological Investigation, 29(5), 450-456.

MEN1 family with a novel frameshift mutation. / Nuzzo, V.; Tauchmanové, L.; Falchetti, A.; Faggiano, A.; Marini, F.; Piantadosi, S.; Brandi, M. L.; Leopaldi, L.; Colao, A.

In: Journal of Endocrinological Investigation, Vol. 29, No. 5, 05.2006, p. 450-456.

Research output: Contribution to journalArticle

Nuzzo, V, Tauchmanové, L, Falchetti, A, Faggiano, A, Marini, F, Piantadosi, S, Brandi, ML, Leopaldi, L & Colao, A 2006, 'MEN1 family with a novel frameshift mutation', Journal of Endocrinological Investigation, vol. 29, no. 5, pp. 450-456.
Nuzzo V, Tauchmanové L, Falchetti A, Faggiano A, Marini F, Piantadosi S et al. MEN1 family with a novel frameshift mutation. Journal of Endocrinological Investigation. 2006 May;29(5):450-456.
Nuzzo, V. ; Tauchmanové, L. ; Falchetti, A. ; Faggiano, A. ; Marini, F. ; Piantadosi, S. ; Brandi, M. L. ; Leopaldi, L. ; Colao, A. / MEN1 family with a novel frameshift mutation. In: Journal of Endocrinological Investigation. 2006 ; Vol. 29, No. 5. pp. 450-456.
@article{fdf42d629bae408280b2aa1f32375bc4,
title = "MEN1 family with a novel frameshift mutation",
abstract = "Multiple endocrine neoplasm type 1 (MEN1) syndrome predisposes to the development of endocrine and non-endocrine tumors with an autosomal dominant pattern of inheritance. Different mutations have been found throughout the gene with a variable phenotype expression. The proband, a Caucasian man, was admitted to our department in 2001, at the age of 51 because of a 1-yr history of diarrhoea and hypertension. He reported a previous intestinal resection for bowel occlusion with a histological diagnosis of unspecified mesenchymal neoplasia. He had also undergone a left adrenalectomy for a large non-functioning adrenal adenoma. Subsequently, he had suffered from gastralgia and melena; a gastroduodenoscopy showed an erosive gastritis. His family history was negative for endocrine disorders. On physical examination, multiple abdominal cutaneous lipomas and facial angiofibromas were observed. Biochemical screening revealed a primary hyperparathyroidism and an increase in circulating levels of PRL, chromogranin-A, gastrin and glucagon. The whole body computed tomography (CT) scan, the 111In-octreotide scan and the pituitary magnetic resonance imaging (MRI) did not reveal any abnormality. The presence of small neuroendocrine tumors was suspected by a positron emission tomography uptake in the epigastric region. The endoscopic ultrasound revealed a pancreatic lesion sized 1.1 cm that is under evaluation. Direct DNA sequencing analysis of the proband MEN1 gene revealed the 579delG frameshift mutation in the exon 3. The genetic screening of the family revealed the same mutation in 3 out of 5 offspring. The biochemical screening revealed some features of the MEN1 syndrome in all three of them. In conclusion, a novel frameshift MEN1 mutation was found in kindred with an apparently negative family history. Our experience confirms that MEN1 syndrome is a complex and underestimated condition, unless specifically investigated by trained specialists.",
keywords = "Cutaneous angiofibromas, Frame-shift mutation, MEN1 syndrome, Menin, Octreoscan octreotide LAR, Primary hyperparathyroidism, Prolactinoma",
author = "V. Nuzzo and L. Tauchmanov{\'e} and A. Falchetti and A. Faggiano and F. Marini and S. Piantadosi and Brandi, {M. L.} and L. Leopaldi and A. Colao",
year = "2006",
month = "5",
language = "English",
volume = "29",
pages = "450--456",
journal = "Journal of Endocrinological Investigation",
issn = "0391-4097",
publisher = "Springer International Publishing",
number = "5",

}

TY - JOUR

T1 - MEN1 family with a novel frameshift mutation

AU - Nuzzo, V.

AU - Tauchmanové, L.

AU - Falchetti, A.

AU - Faggiano, A.

AU - Marini, F.

AU - Piantadosi, S.

AU - Brandi, M. L.

AU - Leopaldi, L.

AU - Colao, A.

PY - 2006/5

Y1 - 2006/5

N2 - Multiple endocrine neoplasm type 1 (MEN1) syndrome predisposes to the development of endocrine and non-endocrine tumors with an autosomal dominant pattern of inheritance. Different mutations have been found throughout the gene with a variable phenotype expression. The proband, a Caucasian man, was admitted to our department in 2001, at the age of 51 because of a 1-yr history of diarrhoea and hypertension. He reported a previous intestinal resection for bowel occlusion with a histological diagnosis of unspecified mesenchymal neoplasia. He had also undergone a left adrenalectomy for a large non-functioning adrenal adenoma. Subsequently, he had suffered from gastralgia and melena; a gastroduodenoscopy showed an erosive gastritis. His family history was negative for endocrine disorders. On physical examination, multiple abdominal cutaneous lipomas and facial angiofibromas were observed. Biochemical screening revealed a primary hyperparathyroidism and an increase in circulating levels of PRL, chromogranin-A, gastrin and glucagon. The whole body computed tomography (CT) scan, the 111In-octreotide scan and the pituitary magnetic resonance imaging (MRI) did not reveal any abnormality. The presence of small neuroendocrine tumors was suspected by a positron emission tomography uptake in the epigastric region. The endoscopic ultrasound revealed a pancreatic lesion sized 1.1 cm that is under evaluation. Direct DNA sequencing analysis of the proband MEN1 gene revealed the 579delG frameshift mutation in the exon 3. The genetic screening of the family revealed the same mutation in 3 out of 5 offspring. The biochemical screening revealed some features of the MEN1 syndrome in all three of them. In conclusion, a novel frameshift MEN1 mutation was found in kindred with an apparently negative family history. Our experience confirms that MEN1 syndrome is a complex and underestimated condition, unless specifically investigated by trained specialists.

AB - Multiple endocrine neoplasm type 1 (MEN1) syndrome predisposes to the development of endocrine and non-endocrine tumors with an autosomal dominant pattern of inheritance. Different mutations have been found throughout the gene with a variable phenotype expression. The proband, a Caucasian man, was admitted to our department in 2001, at the age of 51 because of a 1-yr history of diarrhoea and hypertension. He reported a previous intestinal resection for bowel occlusion with a histological diagnosis of unspecified mesenchymal neoplasia. He had also undergone a left adrenalectomy for a large non-functioning adrenal adenoma. Subsequently, he had suffered from gastralgia and melena; a gastroduodenoscopy showed an erosive gastritis. His family history was negative for endocrine disorders. On physical examination, multiple abdominal cutaneous lipomas and facial angiofibromas were observed. Biochemical screening revealed a primary hyperparathyroidism and an increase in circulating levels of PRL, chromogranin-A, gastrin and glucagon. The whole body computed tomography (CT) scan, the 111In-octreotide scan and the pituitary magnetic resonance imaging (MRI) did not reveal any abnormality. The presence of small neuroendocrine tumors was suspected by a positron emission tomography uptake in the epigastric region. The endoscopic ultrasound revealed a pancreatic lesion sized 1.1 cm that is under evaluation. Direct DNA sequencing analysis of the proband MEN1 gene revealed the 579delG frameshift mutation in the exon 3. The genetic screening of the family revealed the same mutation in 3 out of 5 offspring. The biochemical screening revealed some features of the MEN1 syndrome in all three of them. In conclusion, a novel frameshift MEN1 mutation was found in kindred with an apparently negative family history. Our experience confirms that MEN1 syndrome is a complex and underestimated condition, unless specifically investigated by trained specialists.

KW - Cutaneous angiofibromas

KW - Frame-shift mutation

KW - MEN1 syndrome

KW - Menin

KW - Octreoscan octreotide LAR

KW - Primary hyperparathyroidism

KW - Prolactinoma

UR - http://www.scopus.com/inward/record.url?scp=33745925858&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745925858&partnerID=8YFLogxK

M3 - Article

C2 - 16794369

AN - SCOPUS:33745925858

VL - 29

SP - 450

EP - 456

JO - Journal of Endocrinological Investigation

JF - Journal of Endocrinological Investigation

SN - 0391-4097

IS - 5

ER -